Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 3, 2011
Reporting Period: The filing announces financial results for the three and nine months ended September 30, 2011.
Key Financial Metrics
This Form 8-K serves as a notification of a press release (Exhibit 99.1) containing the financial results. The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the attached press release for these details.
Material Changes
The filing does not contain specific data regarding material changes versus prior periods. It only references the issuance of a press release detailing the results for the period ended September 30, 2011.
Guidance, Outlook, and Risks
Management Commentary: The filing incorporates by reference a press release issued on November 3, 2011, which contains the Company's commentary on operations and financial condition.
Risks and Contingencies: No specific risks or contingencies are detailed in the text of this Form 8-K.
Legal Disclaimer: The information in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section, nor is it incorporated by reference in other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for the three and nine months ended September 30, 2011.
- Verify year-over-year growth rates and margin trends in the attached press release.
- Check for any forward-looking statements or guidance provided in the press release regarding future performance.
- Confirm the status of the Company's liquidity and debt obligations as detailed in the full financial report referenced.